| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2024 | Deschatelets Pascal69 | Chief Scientific Officer | Sell | 3,913 | $65.00 | $254,329.35 | -0.3% | -27.2% | -54.0% | |
| Jan 22, 2024 | Delong Mark Jeffrey76 | Chief Business &Strat Officer | Sell | 1,384 | $65.00 | $89,954.46 | -2.1% | -27.2% | -54.0% | |
| Jan 22, 2024 | Chopas James George80 | Vp/ Chief Accounting Officer | Sell | 1,061 | $65.00 | $68,960.76 | -2.6% | -27.2% | -54.0% | |
| Jan 17, 2024 | Eisele Jeffrey76 | Chief Development Officer | Sell | 5,207 | $65.58 | $341,475.06 | -7.2% | -21.4% | -54.9% | |
| Jan 17, 2024 | Lewis Karen76 | Chief People Officer | Sell | 3,276 | $65.58 | $214,840.08 | -5.8% | -21.4% | -54.9% | |
| Jan 16, 2024 | Chopas James George80 | Vp/ Chief Accounting Officer | Sell | 864 | $66.81 | $57,722.63 | -2.1% | -22.3% | -56.2% | |
| Jan 16, 2024 | Lewis Karen76 | Chief People Officer | Sell | 1,632 | $66.81 | $109,031.64 | -2.8% | -22.3% | -56.2% | |
| Jan 16, 2024 | Delong Mark Jeffrey76 | Chief Business &Strat Officer | Sell | 1,631 | $66.81 | $108,964.83 | -2.4% | -22.3% | -56.2% | |
| Jan 16, 2024 | Nicholson Nur82 | Chief Technical Officer | Sell | 1,857 | $66.81 | $124,063.57 | -2.6% | -22.3% | -56.2% | |
| Jan 16, 2024 | Sullivan Timothy Eugene85 | Chief Financial Officer | Sell | 2,235 | $66.81 | $149,317.22 | -2.2% | -22.3% | -56.2% |